Systemic sclerosis & Raynaud's

Association of Type III and Type VI Collagen Neoepitopes With Disease Severity in Systemic Sclerosis

J RheumatolPublished Cohort study

Authors' conclusion

PRO-C3 and PRO-C6 correlated with skin disease severity, whereas C3M and C6M correlated with lung disease severity. Collagen turnover biomarkers correlated with CRP, IL-6, and IFN-inducible proteins, providing support for the link between inflammation and fibrosis in SSc.

Study context

Population
Patients with early systemic sclerosis (SSc) in the Collaborative National Quality and Efficacy Registry (CONQUER) cohort
Participants
222 patients
Outcome
Collagen turnover biomarkers vs disease severity
Follow-up
Baseline
Methodological detailsbiomarker analysis, baseline and 6-month serum samples
  • Biomarker analysis
  • Baseline and 6-month serum samples

Main finding

As reported in the abstract

PRO-C3 concentrations higher in diffuse disease
P < 0.001
PRO-C6 concentrations higher in diffuse disease
P < 0.001
C6M higher in ILD
P = 0.04
Baseline PRO-C3 positively correlated with mRSS
P < 0.001
Baseline PRO-C6 positively correlated with mRSS
P < 0.001
C3M negatively correlated with FVC%
P = 0.03
C6M negatively correlated with FVC%
P = 0.01
Magnitude of correlations in the weak range
rs < 0.4

Observational data: associations, not effects.

Further findings

Changes in biomarkers vs changes in C-reactive protein (CRP) and interferon (IFN) score · 6 months

Changes in CRP positively correlated with changes in collagen degradation proteins (C3M and C6M), not with changes in formation proteins (PRO-C3 and PRO-C6)
Changes in IFN score showed the highest correlation with changes in PRO-C6

Original publication

Association of Type III and Type VI Collagen Neoepitopes With Disease Severity in Systemic Sclerosis. J Rheumatol. Published 15 November 2025. doi:10.3899/jrheum.2025-0532

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.